Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1977 Mar;59(3):528–535. doi: 10.1172/JCI108668

Angiotensin antagonists with increased specificity for the renal vasculature.

K J Taub, W J Caldicott, N K Hollenberg
PMCID: PMC333390  PMID: 190270

Abstract

This study was designed to ascertain whether renal vascular angiotensin receptors differ from other systemic angiotensin receptors and whether, on that basis, antagonists with greater specificity for the renal vasculature can be defined. Femoral and renal blood flow and their responses to angiotensin II (AII) and its heptapeptide analogue, 1-des Asp AII (AIII), were measured with an electromagnetic flowmeter in 26 dogs. For the kidney, the threshold doses of AII and AIII were identical (2.5+/-0.27 vs. 2.3+/-0.35 pmol/100 ml renal blood flow, with similar dose-response curves. In contrast, AII had a greater pressor effect (P less than 0.001) and produced more femoral vasoconstriction (P less than 0.001) than AIII. All four antagonists studied (1-Sar, 8-Ala AII [P113]; 8-Ala AII; 1-des Asp, 8-Ala AII; 1-des Asp, 8-Ile AII) induced parallel shifts in the renal blood flow response to AII and AIII. P113 induced greater blockade than 8-Ala AII (P less than 0.001) which, in turn, was more effective than 1-des Asp, 8-Ala AII (P less than 0.001). 1-des Asp, 8-Ile AII was as effective as P113. Each analogue induced an identical inhibition of the renal vascular response to AII and AIII. In addition, AII and AIII induced cross-tachyphylaxis. All lines of evidence suggested that AII and AIII act on a single receptor in the kidney, which differs at least functionally from other systemic vascular receptors. The possibility that heptapeptide analogues represent angiotensin antagonists with greater specificity for the renal vasculature was pursued in a model in which the renin-angiotensin system is activated. Acute, partial thoracic inferior vena caval occlusion was induced in an additional 16 dogs. P113 induced progressive, dose-related hypotension and a limited increase in renal blood flow in this model. The 1-des Asp, 8-Ile AII analogue, conversely, induced a consistent, larger, dose-related renal blood flow increase, with significantly less hypotension over a wide dose range. We conclude that the renal vascular receptor differs sufficiently from systemic angiotensin receptors that heptapeptide analogues of AII will be useful in exploring angiotensin's role in states characterized by disordered renal perfusion and function.

Full text

PDF
528

Images in this article

533Image
on p.533

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bravo E. L., Khosla M. C., Bumpus F. M. Action of (1-des(aspartic acid), 8-isoleucine) angiotensin II upon the pressor and steroidogenic activity of angiotensin II. J Clin Endocrinol Metab. 1975 Mar;40(3):530–533. doi: 10.1210/jcem-40-3-530. [DOI] [PubMed] [Google Scholar]
  2. Burger B. M., Hopkins T., Tulloch A., Hollenberg N. K. The role of angiotensin in the canine renal vascular response to barbiturate anesthesia. Circ Res. 1976 Mar;38(3):196–202. doi: 10.1161/01.res.38.3.196. [DOI] [PubMed] [Google Scholar]
  3. Caldicott W. J., Hollenberg N. K., Abrams H. L. Characteristics of response of renal vascular bed to contrast media. Evidence for vasoconstriction induced by renin-angiotensin system. Invest Radiol. 1970 Nov-Dec;5(6):539–547. doi: 10.1097/00004424-197011000-00021. [DOI] [PubMed] [Google Scholar]
  4. Cannon P. J., Ames R. P., Laragh J. H. Indirect action of angiotensin infusion to inhibit renal tubular sodium reabsorption in dogs. Am J Physiol. 1966 Oct;211(4):1021–1030. doi: 10.1152/ajplegacy.1966.211.4.1021. [DOI] [PubMed] [Google Scholar]
  5. Freeman R. H., Davis J. O., Lohmeier T. E. Des-1-Asp-angiotensin II. Possible intrarenal role in homeostasis in the dog. Circ Res. 1975 Jul;37(1):30–34. doi: 10.1161/01.res.37.1.30. [DOI] [PubMed] [Google Scholar]
  6. Freeman R. H., Davis J. O., Spielman W. S., Lohmeier T. E. High-output heart failure in the dog: systemic and intrarenal role of angiotensin II. Am J Physiol. 1975 Aug;229(2):474–478. doi: 10.1152/ajplegacy.1975.229.2.474. [DOI] [PubMed] [Google Scholar]
  7. Freeman R. H., Davis J. O., Vitale S. J., Johnson J. A. Intrarenal role of angiotensin II. Homeostatic regulation of renal blood flow in the dog. Circ Res. 1973 Jun;32(6):692–698. doi: 10.1161/01.res.32.6.692. [DOI] [PubMed] [Google Scholar]
  8. Gutman R. A., Forrey A. W., Fleet W. P., Cutler R. E. Vasopressor-induced natriuresis and altered intrarenal haemodynamics in cirrhotic man. Clin Sci. 1973 Jul;45(1):19–34. doi: 10.1042/cs0450019. [DOI] [PubMed] [Google Scholar]
  9. Hollenberg N. K., Solomon H. S., Adams D. F., Abrams H. L., Merrill J. P. Renal vascular responses to angiotensin and norepinephrine in normal man. Effect of sodium intake. Circ Res. 1972 Nov;31(5):750–757. doi: 10.1161/01.res.31.5.750. [DOI] [PubMed] [Google Scholar]
  10. Hollenberg N. K., Williams G. H., Burger B., Ishikawa I., Adams D. F. Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man. J Clin Invest. 1976 Jan;57(1):39–46. doi: 10.1172/JCI108266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Khairallah P. A. Action of angiotensin on adrenergic nerve endings: inhibition of norepinephrine uptake. Fed Proc. 1972 Jul-Aug;31(4):1351–1357. [PubMed] [Google Scholar]
  12. Khairallah P. A., Toth A., Bumpus F. M. Analogs of angiotensin II. II. Mechanism of receptor interaction. J Med Chem. 1970 Mar;13(2):181–184. doi: 10.1021/jm00296a003. [DOI] [PubMed] [Google Scholar]
  13. Kilcoyne M. M., Cannon P. J. Influence of thoracic caval occlusion on intrarenal blood flow distribution and sodium excretion. Am J Physiol. 1971 May;220(5):1220–1230. doi: 10.1152/ajplegacy.1971.220.5.1220. [DOI] [PubMed] [Google Scholar]
  14. Laragh J. H., Cannon P. J., Bentzel C. J., Sicinski A. M., Meltzer J. I. ANGIOTENSIN II, NOREPINEPHRINE, AND RENAL TRANSPORT OF ELECTROLYTES AND WATER IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES. J Clin Invest. 1963 Jul;42(7):1179–1192. doi: 10.1172/JCI104803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. MANDEL M. J., SAPIRSTEIN L. A. Effect of angiotensin infusion on regional blood flow and regional vascular resistance in the rat. Circ Res. 1962 May;10:807–816. doi: 10.1161/01.res.10.5.807. [DOI] [PubMed] [Google Scholar]
  16. Mimran A., Hinrichs K. J., Hollenberg N. K. Characterization of smooth muscle receptors for angiotensin: studies with an antagonist. Am J Physiol. 1974 Jan;226(1):185–190. doi: 10.1152/ajplegacy.1974.226.1.185. [DOI] [PubMed] [Google Scholar]
  17. Peach M. J., Bumpus F. M., Khairallah P. A. Inhibition of norepinephrine uptake in hearts by angiotensin II and analogs. J Pharmacol Exp Ther. 1969 Jun;167(2):291–299. [PubMed] [Google Scholar]
  18. Regoli D., Park W. K., Rioux F., Chan C. S. Antagonists of angiotensin. Substitution of an aliphatic chain to phenyl ring in position 8. Rev Can Biol. 1971 Dec;30(4):319–329. [PubMed] [Google Scholar]
  19. Sarstedt C. A., Vaughan E. D., Jr, Peach M. J. Selective inhibition by des-1-Asp-8-lle-angiotensin ii of the steroidogenic response to restricted sodium intake in the rat. Circ Res. 1975 Sep;37(3):350–358. doi: 10.1161/01.res.37.3.350. [DOI] [PubMed] [Google Scholar]
  20. Sasaki H., Okumura M., Ikeda M., Kawasaki T., Fukiyama K. Letter: Hypotensive response to angiotensin II analogue in Bartter's syndrome. N Engl J Med. 1976 Mar 11;294(11):611–612. doi: 10.1056/nejm197603112941115. [DOI] [PubMed] [Google Scholar]
  21. Slick G. L., DiBona G. F., Kaloyanides G. J. Renal blockade to angiotensin II in acute and chronic sodium-retaining states. J Pharmacol Exp Ther. 1975 Nov;195(2):185–193. [PubMed] [Google Scholar]
  22. Steele J. M., Jr, Lowenstein J. Differential effects of an angiotensin II analogue on pressor and adrenal receptors in the rabbit. Circ Res. 1974 Oct;35(4):592–600. doi: 10.1161/01.res.35.4.592. [DOI] [PubMed] [Google Scholar]
  23. Watkins L., Jr, Burton J. A., Haber E., Cant J. R., Smith F. W., Barger A. C. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. J Clin Invest. 1976 Jun;57(6):1606–1617. doi: 10.1172/JCI108431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Williams G. H., McDonnell L. M., Raux M. C., Hollenberg N. K. Evidence for different angiotensin II receptors in rat adrenal glomerulosa and rabbit vascular smooth muscle cells. Studies with competitive antagonists. Circ Res. 1974 Mar;34(3):384–390. doi: 10.1161/01.res.34.3.384. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES